Role of 18FFDG PET/CT in the treatment of head and neck cancers: Principles, technique, normal distribution, and initial staging

American Journal of Roentgenology

Volumn 184, Issue 2, 2005, Pages 579-587

  Kapoor, Vibhu ^a,b   Fukui, Melanie B ^c   McCook, Barry M ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b Allegheny General Hospital ^*  (United States)

^c ALLEGHENY GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT; DIAGNOSTIC AGENT;

ADULT; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; LYMPHADENOPATHY; MALE; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; COMPUTER ASSISTED EMISSION TOMOGRAPHY; HEAD AND NECK TUMOR; INTERVENTIONAL RADIOLOGY; LYMPH NODE METASTASIS; RADIOGRAPHY; SCINTISCANNING;

FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM STAGING; RADIOGRAPHY, INTERVENTIONAL; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 15944423964     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.184.2.01840579     Document Type: Review

References (18)

1. Kostakoglu L, Agress H Jr., Goldsmith SJ. Clinical role of FDG PET in evaluation of cancer patients. RadioGraphics 2003;23:315-340
2. Reinhardt MJ, Kubota K, Yamada S, Iwata R, Yaegashi H. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J Nucl Med 1997;38:280-287
3. Kapoor V, McCook BM, Torok FS. An introduction to PET-CT imaging. RadioGraphics 2004;24:523-543
4. Steinert HC, Hauser M, Allemann F, et al. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology 1997;202:441-446
5. Abdel-Nabi H, Doerr RJ, Lamonica DM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998;206:755-760
6. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-1379
7. Warburg O, Posener K, Negelein E. On the metabolism of cancer cells. Biochem Z 1924;152:319-344
8. Wahl RL. Targeting glucose transporters for tumor imaging: "sweet" idea, "sour" result. J Nucl Med 1996;37:1038-1041
9. Fukui MB, Meltzer CC, Snyderman C, et al. Combined PET/CT: physiologic/anatomic atlas of F-18 fluorodeoxyglucose (FDG) uptake on PET imaging in the head and neck. Neurographics 2001;1:1
10. Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. RadioGraphics 1999;19:61-77
11. Zbaren P, Becker M, Lang H. Pretherapeutic staging of laryngeal carcinoma: clinical findings, computed tomography and magnetic resonance imaging compared with histopathology. Cancer 1996;77:1263-1273
12. Mukherji SK, Fischbein NJ, Castelijns JA. New imaging techniques. In: Som PM, Curtin HD, eds. Head and neck imaging, 4th ed. St. Louis, MO: Mosby, 2003:2294-2322
13. Muraki AS, Mancuso AA, Harnsberger HR. Metastatic cervical adenopathy from tumors of unknown origin: the role of CT. Radiology 1984;152:749-753
14. Adams S, Baum RP, Stuckensen T, et al. Prospective comparison of 18F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer. Eur J Nucl Med 1998;25:1255-1260
15. Jones AS, Roland NJ, Field JK, Phillips DE. The level of cervical lymph node metastases: their prognostic relevance and relationship with head and neck squamous carcinoma primary sites. Clin Otolaryngol 1994;19:63-69
16. Assar OS, Fischbein NJ, Caputo GR, et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology 1999;210:177-181
17. Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J. Second neoplasm in patients with head and neck cancer. Head Neck 1999;21:204-210
18. Manolidis S, Donald PJ, Volk P, Pounds TR. The use of positron emission tomography scanning in occult and recurrent head and neck cancer. Acta Otolaryngol Suppl 1998;534:1-11